Design of Dual Inhibitors of Soluble Epoxide Hydrolase and LTA4 Hydrolase-Reference-Cited by-同舟云学术

Design of Dual Inhibitors of Soluble Epoxide Hydrolase and LTA4 Hydrolase

Published:2019-10-30 Issue:3 Volume:11 Page:298-302
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Hiesinger Kerstin¹,Schott Annika¹,Kramer Jan S.¹,Blöcher René¹,Witt Finja²,Wittmann Sandra K.¹,Steinhilber Dieter¹,Pogoryelov Denys¹,Gerstmeier Jana²,Werz Oliver²,Proschak Ewgenij¹^ORCID

Affiliation:

1. Institute of Pharmaceutical Chemistry, Goethe University Frankfurt, Max-von-Laue-Strasse 9, 60438 Frankfurt, Germany

2. Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich-Schiller-University Jena, Philosophenweg 14, 07743 Jena, Germany

Funder

Carl-Zeiss-Stiftung

Deutsche Forschungsgemeinschaft

Else Kr?ner-Fresenius-Stiftung

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.9b00330

Reference19 articles.

1. Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases